Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology

Go back to Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
(NASDAQ: GCTK) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High
Open $0.36    52 Week Low
Day High $0.36    P/E N/A 
Day Low $0.36    EPS
Volume 4,307